Paula Brock, Ph.D., MCSI

Works directly with EAS’ Senior Director, Labeling, Cannabis and Claims Consulting Services to assure client satisfaction and project management. She collaborates with EAS consultants and clients to provide excellence in service. Dr. Brock facilitates food, dietary supplement, and cosmetic label compliance reviews, develops marketing materials for FDA and FTC compliance, including claims substantiation. She provides scientific services such as clinical study design, data analysis, herb-drug interaction studies, product formulation, safety and efficacy of ingredients, ingredient monograph writing, safety opinions, adverse event investigations, and develops claims and slides for marketing purposes. She serves as GRAS and NDI expert panelist.

Dr. Brock has 22 years of experience in pharmacology and toxicology. Her first 13 years in academia she specialized in clinical and preclinical research, neuroscience, analytical and clinical pharmacology, molecular biology, and personalized medicine. Her last 9 years in industry she added US and international regulations on dietary supplements, cosmetics, drug-herb interaction, adverse event investigations, safety and efficacy claims substantiation, product formulation, and public speaking. Dr. Brock has held Senior Director positions in Scientific and Regulatory Affairs with the U.S. dietary supplement/cosmetic industry. Dr. Brock’s Ph.D. is in Pharmacology and Toxicology from the University of Utah, Master of Science in Clinical Investigation from Howard Hughes Medical Institute, and bachelor’s in chemistry and pharmacy.

Recent articles:

1. Andersen A, Vieira-Brock PL, Vaughan B, Vollmer D. Method development for the analysis of PBMC-mediated killing of K562 cells by bovine colostrum. J Immunol Methods. 2021 Dec;499:113175.
2. Vieira-Brock, P. (2022). Safety Review of Herbs and Supplements in Heart Disease, Diabetes, and COVID-19. IntechOpen. doi: 10.5772/intechopen.96811. Available from: https://www.intechopen.com/online-first/75758
3. Vieira-Brock PL, et al. Thermogenic blend alone or in combination with whey protein supplement stimulates fat metabolism and improves body composition in mice. Pharmacognosy Res (2018) 10(1): 37-43
4. Vieira-Brock PL, et al. Comparison of antimicrobial activities of natural essential oils and synthetic fragrances against selected environmental pathogens. Biochim Open (2017) 5: 8-13.
5. McFadden LM and Vieira-Brock PL. The persistent neurotoxic effects of methamphetamine on dopaminergic and serotonergic markers in male and female rats. Toxicol Open Access (2016) 2 (2)
6. Vieira-Brock PL, McFadden LM, Nielsen SM, Ellis JD, Stout KA, Walters ET, Wilkins DG, McIntosh JM, Hanson GR, Fleckenstein AE. Chronic nicotine exposure attenuates methamphetamine-induced dopaminergic deficits. J Pharm Exp Ther (2015)355(3): 463-72.
7. Vieira-Brock PL, McFadden LM, Nielsen SM, Smith GR, Hanson GR, Fleckenstein AE. Nicotine attenuates methamphetamine-induced novel object recognition deficits. The International Journal of Neuropsychopharmacology. (2015)18(12)pii:pyv073.
8. Vieira-Brock PL, Andrenyak DM, Nielsen SN, Fleckenstein AE, Wilkins DG. Age-related differences in the disposition of nicotine and metabolites in rat brain and plasma. Nicotine Tob Res (2013) 15:1839-48.
9. Vieira-Brock PL, Miller EI, Nielsen SM, Fleckenstein AE, Wilkins DG. Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography tandem mass spectrometry. J Chromatography B (2011) 879: 3465-74.

Posted in Who’s Who at EAS.